Dupilumab News
Dupilumab currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Dupilumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Atopic dermatitis Adults and adolescentsDupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic...
- Evidence level: L5
- Predicted indications (20):
- bronchitis (99.9%)
- dermatitis (99.7%)
- acne keloid (99.6%)
- exanthem (disease) (99.6%)
- neonatal dermatomyositis (99.6%)
- acrodermatitis chronica atrophicans (99.5%)
- amyopathic dermatomyositis (99.5%)
- secondary interstitial lung disease specific to childhood associated with a connective tissue disease (99.5%)
- hydroa vacciniforme, familial (99.5%)
- atopic eczema (99.3%)
- severe nonproliferative diabetic retinopathy (99.1%)
- postinfectious vasculitis (98.8%)
- post-bacterial disorder (98.8%)
- infective urethral stricture (98.7%)
- post-infectious syndrome (98.7%)
- infection-related hemolytic uremic syndrome (98.7%)
- Chagas cardiomyopathy (98.7%)
- otitis externa (98.4%)
- pityriasis simplex (98.2%)
- bronchial neoplasm (disease) (98.2%)
Related News (1)
Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost
2026-10-10 EPOC
Source: Le HuffPost
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.